Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04951115
What this trial is testing

A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Weill Medical College of Cornell University 6
Very early researchUnknownNCT01620749
What this trial is testing

Of 18F MEL050 Using PET/CT in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Cooperative Research Centre for Biomedical Imaging Development 12
Not applicableNot Yet RecruitingNCT07054047
What this trial is testing

Improving Diagnosis and Treatment for Patients With Rectal Cancer

Who this might be right for
GI Cancer
Imperial College London 438
Testing effectiveness (Phase 2)Study completedNCT00553098
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders

Who this might be right for
Immunodeficiency SyndromeNon-Cancer Diagnosis
Fred Hutchinson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Not applicableLooking for participantsNCT06779747
What this trial is testing

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

Who this might be right for
HypothyroidismHyperthyroidism/ThyrotoxicosisThyroid Nodule (Benign)+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 5,850
Testing effectiveness (Phase 2)Study completedNCT00075881
What this trial is testing

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 44
Not applicableUnknownNCT01836822
What this trial is testing

Bronchoscopic Sampling Techniques in Sarcoidosis

Who this might be right for
Mediastinal Lymph Node EnlargementSarcoidosisTuberculosis+1 more
Medical University of Warsaw 90
Not applicableEnded earlyNCT01303419
What this trial is testing

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare 224
Not applicableUnknownNCT03938012
What this trial is testing

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the LungSquamous Cell Carcinoma of the Head and Neck
National University Hospital, Singapore 80
Not applicableActive Not RecruitingNCT05677594
What this trial is testing

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Atypical Neurofibroma
Johns Hopkins University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06158269
What this trial is testing

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 40
Not applicableStudy completedNCT01004523
What this trial is testing

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 135
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00220129
What this trial is testing

Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

Who this might be right for
Oesophageal Carcinoma
Royal Marsden NHS Foundation Trust 16
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00838656
What this trial is testing

Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Warwick Medical School 88
Testing effectiveness (Phase 2)Study completedNCT04525131
What this trial is testing

Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors

Who this might be right for
Bladder Cancer
CicloMed LLC 12
Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Next Page